Systemic and lung-resident memory elicited by OC43 coronavirus infection in mice
Abstract
Abstract Endemic coronaviruses circulate seasonally and, while typically mild, can produce robust inflammation and severe pneumonia. Immunological memory to coronaviruses can be cross-reactive for multiple coronaviruses including OC43 and SARS-CoV-2. In this study, we used mouse models to investigate immune responses elicited by pulmonary infection with OC43. OC43 caused a mild, self-limiting infection. Early after infection, there was acute influx of myeloid cells and lymphocytes to the lung as well as a type I interferon–dependent production of IFN-γ. However, blocking interferons did not enhance viral infection. After recovery, lungs contained resident memory lymphocytes, and both the blood and lungs contained antibodies against OC43. When infection was supplemented with proinflammatory stimuli to model more severe disease, OC43-elicited immune changes were bolstered, including increased virus-specific plasma IgG and lung IgA, enhanced lung B-cell class-switching, and increased antigen-specific Th1 and Th17 cytokine production from lung CD4+ T cells. The antibodies and CD4+ T cells in mice recovered from OC43 infection, even with immunostimulatory agents, reacted only with OC43 proteins and peptides and not with those from other coronaviruses. Therefore, OC43 infection in wild-type mice does not induce the heterotypic immunity observed in humans. In conclusion, OC43 induces a self-limiting lung infection in mice accompanied by homotypic lung-resident and systemic memory, amplified by proinflammatory stimuli during infection.
Article Details
Journal Info
The Journal of Immunology
American Association of Immunologists
Authors (14)
Nathan L Sanders
Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,
Devin Kenney
Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine
Neelou S Etesami
Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,
Anukul T Shenoy
Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,
Konstantinos Kontodimas
Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,
Julian Amirault
Boston University Chobanian and Avedisian School of Medicine
Chioma Okolo
Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,
Viviana A Dominguez
Department of Medicine, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,
Marc Semaan
Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine
Ekaterina Murzin
Department of Surgery, Brigham and Women’s Hospital and Harvard Medical School , Boston, MA,
James A Lederer
Department of Surgery, Brigham and Women’s Hospital and Harvard Medical School , Boston, MA,
Florian Douam
National Emerging Infectious Diseases Laboratories, Boston University
Mohsan Saeed
Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine
Joseph P Mizgerd
Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA,